Pα+ Psychedelic Bulletin #219: Trump Admin. Vetoed Compass Priority Voucher; Ibogaine in Focus; Definium Sued by Former Vendor; Psychedelics Feature in Epstein Files
Trump Administration Vetoed Compass Pathways Priority Voucher • Ibogaine in Focus (State Bills Progress, Safety and Regulation, State Programs and Global Supply, Drug Development Remains Early-Stage, DemeRx Shares Phase 1 Data • Definium Therapeutics Sued by Former Vendor Over Alleged Trade Secret Theft • Psychedelics Surface in Newly Released Epstein Documents • Fresh State Bills Add to Growing Psychedelics Docket • and more…
External link. We are not responsible for the content.
Read more ↗More From Psychedelic Alpha
Pα+ Psychedelic Bulletin #221: Helus Reports Murky Phase 2a Results; AtaiBeckley Says R-MDMA Met Safety Goal in SAD, Details Phase 3 Design for 5-MeO-DMT in TRD; Psilocybin for Smoking Cessation Study Published
Policy Round-Up: State Momentum, Congressional Signals, and Colorado’s Data Build-Out • RAND Survey: Americans Divi...
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
AtaiBeckley is in structured discussions with pharma companies and royalty investors about a potential partnership fo...
Pα+ February 2026 Psychedelic Bill Roundup
A state-by-state and federal review of psychedelics-related bills introduced or advanced in February 2026, including ...
Latest News
The Difficulty of Sincerity After Psychedelics
Psychedelic experiences often heighten one’s sense of authenticity and sincerity, but this can make ordinary social i...
Less than a month away!
plus new lineup and talks announced!
Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.
President Donald Trump’s April 2026 executive order on accelerating treatments for serious mental illness does someth...
Trump Signs Executive Order To Fast-Track Psychedelic Research
President Donald Trump signed an executive order aimed at accelerating clinical research and federal approval for psy...
Whitehouse Directs FDA, HHS and VA to Expand Psychedelic Research Pathways
The White House moved to accelerate federal handling of psychedelic drugs, including ibogaine, while leaving core app...
Can an LLM get high? 5 Questions with clinical neuroscientist Ziv Ben-Zion
Ben-Zion discusses how artificial intelligence mimics the psychedelic experience.